ãããã質å
NIPTæ€æ»ã«ã€ããŠ
茞éæãã©ãã«ã倩çœãªã©ã«ãã貚ç©é 延ã®å Žåãããçšã«åæ€æ»ãå¿ èŠãªå ŽåããããŸãã
ãã®éã«ã¯ãNIPT JapanïŒåœç€ŸïŒãããé£çµ¡ãããŠããã ããŸãã
åæ€æ»ã®è²»çšã¯ãç¡æã§ãã
ãã£ã³ã»ã«ãåžæã®å Žåã«ã¯ãå šé¡è¿éãããŠããã ããŸãã
NIPTã§åæ€æ»ãå¿ èŠãªå Žå
â èå DNAäžè¶³ã®å Žå
â¡æº¶è¡ã®å ŽåïŒèµ€è¡çãäœããã®åå ã«ããç Žå£ãããããšã§æ€æ»ããã ããªãç¶æ ïŒ
â¢å€å®ä¿çã®å ŽåïŒæè¬ã®åœ±é¿ãªã©ã§æ€æ»åæåºãªãã£ãå ŽåïŒ
â£èŒžéæãã©ãã«ã倩çœãªã©ã«ãã貚ç©é 延ã®å Žå
èå
ã®äººæ°ã«ãããåãããã ããæ€æ»ãéããŸãã®ã§ãNIPTæ€æ»ããåæ€ãããåã«å¿
ãæ€èšºããåãããã ããããé¡ãç³ãäžããŸãã
ãªãããäºçŽããåãããããšã¯å¯èœã§ããããäºçŽããã ããåŸã«æ€èšºã®çµæãåèåŠåš ãå€æããå Žåã¯ãåŒç€ŸãŸã§ãé£çµ¡ããé¡ãããŠãããŸãã
åèåŠåš ã®å Žå
æ€æ»ïŒïŒïŒããªãœããŒãïŒïŒããªãœããŒãïŒïŒããªãœããŒã®ïŒçš®ã®æè²äœç°æ°æ§æ€æ»ïŒãå¯èœã§ãã
æ€æ»ïŒå
šæè²äœç°æ°æ§æ€æ»ïŒãæ€æ»ïŒå
šæè²äœç°æ°æ§æ€æ»ïŒåŸ®å°æ¬ 倱çæ€æ»ïŒã¯ãæ€æ»ç²ŸåºŠã®ä¿èšŒãã§ããªãçºãåèåŠåš 以å€ã¯ãåãããã ãããšãã§ããŸããã
æ§å¥å€æïŒç·å ã®å Žåã©ã¡ãããç·å ããããã¯2人ãšãç·å ãšããå€å®ïŒã¯ã§ããŸãããæ§æè²äœç°æ°æ§ã®æ€æ»ã¯ã§ããŸããã
3ã€å以äžã®å€èåŠåš ã®å Žå
å šãŠã®æ€æ»ããåãããã ãããšãã§ããŸããã
ããã·ã³ã°ãã€ã³ã®å Žå
å šãŠã®æ€æ»ããåãããã ããŸãã
ãªããæé·ãæ¢ãŸã£ãŠããåã®DNAãæ¯äœã«å®å šã«åžåãããŠããªãå Žåãçµæã«åœ±é¿ãåãŒãå¯èœæ§ããããŸãã
https://niptjapan.com/faq/vanishingtwin-nipt/
ãã¹ãŠã®æ€æ»ã³ãŒã¹ããåãããã ããŸãã
èå¢ïŒããã®ãïŒãããç¶æ
ã§ãæ€æ»ã¯å¯èœã§ããæé·ã®æ¢ãŸã£ãŠããåã®åœ±é¿ãåãåœéœæ§ã«ãªãå¯èœæ§ããããã泚æãå¿
èŠã§ãã
ããã·ã³ã°ãã€ã³ã«ã€ããŠã¯ãã³ã©ã ïŒååã®åŠåš ã§èµ·ããããã·ã³ã°ãã€ã³ãšã¯ïŒãããåèã«ããŠãã ããã
åœç€Ÿãåãæ±ãNIPTæ€æ»ã®Verifiâã¯ãç±³åœã®CLIAããã³CAPã®èªå¯ãåããVerinata Health瀟ãéããŠæäŸãããŠããNIPTæ€æ»ã§ãã
CLIAãšã¯
CLIAïŒClinical Laboratory Improvement AmendmentsïŒã¯ 1988 幎ã«ç±³åœé£éŠæ¿åºãæ³åŸãšããŠå¶å®ããèšåºæ€æ»å®€æ¹åæ³ïŒCLIAæ³ïŒã§ãã
ç±³åœå ã®å šãŠã®èšåºæ€æ»å®€ã¯ãæ³ã«åºã¥ãCLIAèªå®ãåããªããã°ãªããŸãããCAPãšã¯
CAPïŒCollege of American PathologistsïŒã¯ç±³åœç çåŠäŒã®æå³ã
NIPTã®æ¡è¡éã¯ãæ€æ»ã®çš®é¡ã«é¢ãããçŽ10mlã§ãã
Verinata Health, Inc.ïŒç±³åœã»ã«ãªãã©ã«ãã¢ïŒã§ãã
å瀟ã¯ãIllumina, Inc.ïŒç±³åœã»ã«ãªãã©ã«ãã¢ãNASDAQ: ILMNïŒã®100%åäŒç€Ÿã§ãã
æçšäžã§ãæ€æ»ã¯ãåãããã ããŸãã
æ€æ»åœæ¥ãåææžã®è£èšæ¬ã«ã䜿çšäžã®è¬ååããèšå
¥ãã ããã
åœç€Ÿã§ã¯ã10é±0æ¥ãã15é±6æ¥ãŸã§ãæšå¥šãããŠããã ããŠãããŸãã
16é±ãè¶
ããŠããåæ€ããã ããŸããããäºçŽåã«åœç€ŸãŸã§å¿
ããåãåãããã ããã
æ€æ»å 容ã®éã
æ¯äœè¡æž
ããŒã«ãŒæ€æ»ã¯ãåŠå©Šããã®è¡æ¶²äžã«å«ãŸããæåïŒAFP, uE3, hCG, InhibinA å€ïŒã枬å®ããèå
ã®21ããªãœããŒïŒããŠã³çå矀ïŒã18ããªãœããŒãéæŸæ§ç¥çµç®¡å¥åœ¢ïŒäºåèæ€ãç¡è³çãªã©ïŒã®ç¢ºçãç®åºããæ€æ»ã§ããïŒåŠåš 15ïœ18é±ïŒ
NIPTãšæ¯èŒãããšæ€æ»ç²ŸåºŠã¯äœãã§ãã
äžæ¹ãNIPTã¯ãç¡äŸµè¥²çåºçåéºäŒåŠçæ€æ»ïŒNon-invasive prenatal genetic testing, ç¥ç§°: NIPTïŒã®ããšã§ãããåŠå©Šããã®è¡æ¶²ãæ¡åããæ¯äœè¡äžã®èå ã®DNAæçãåæããèå ãæè²äœç°åžžçãéºäŒåç°åžžçãæã£ãŠãããã©ããã®å¯èœæ§ã調ã¹ãæ€æ»ã§ããïŒåŠåš 10é±0æ¥ä»¥éïŒ
NIPTã®ç¹é·ã¯ãæ¯äœè¡æž ããŒã«ãŒæ€æ»ãšæ¯ã¹ããšå€å®ã®ç²ŸåºŠãéåžžã«é«ãæ€æ»ã§ãç¹ã«é°æ§ãšå€æãããå Žåã®å®éã«é°æ§ã§ãã確çã¯99%以äžãšéåžžã«é«ããããããåŠåš 10é±0æ¥ä»¥éãšæ©ãææã«æ€æ»ãè¡ãããšãã§ããããšãç¹çããç¹ã§ãã
è²»çšã®éã
è²»çšã¯ç
é¢ã«ãã£ãŠç°ãªããŸãããæ¯äœè¡æž
ããŒã«ãŒæ€æ»ã¯3äžåååŸã§ãã
NIPTã®æ€æ»è²»çšã¯æ€æ»ã¡ãã¥ãŒãç
é¢ã«ãã£ãŠç°ãªããŸãããæŠã20äžåååŸã§ãã
ãšãã«é確å®èšºææ€æ»
æ¯äœè¡æž
ããŒã«ãŒæ€æ»ãNIPTãšãã«ãé確å®èšºææ€æ»ã§ãã
ãã®ãããçµæãéœæ§ã§ãã£ãå Žåã¯ãã©ã¡ãã®æ€æ»ã§ãã£ããšããŠãã確å®çæ€æ»ã§ããçŸæ°Žæ€æ»ãåãããåŠãã®éžæãè¡ãå¿
èŠããããŸãã
åœç€Ÿã®ã³ã©ã ãæ¯äœè¡æž ããŒã«ãŒãšã¯ïŒNIPTãšã¯ã©ãéãïŒãããåç §ãã ããã
åŠåš 10é±0æ¥ä»¥éã§ããã°ãã€ã§ãæ€æ»å¯èœã§ããã€ãŸã§ã«åããªããã°ãªããªããšããããšã¯ããããŸããã
ãã ã33é±ä»¥éãšãªããŸããšåºç£åŸã«æ€æ»éç¥ãå±ãå¯èœãããããŸãã
ïŒæ€æ»ã®ãäºçŽã¯åŠåš é±æ°ã«é¢ä¿ãªããã€ã§ãå¯èœã§ããïŒ
åœç€Ÿã§ã¯ã15é±ãããŸã§ã®æ€æ»ãæšå¥šããŠãããŸãã
åºçå蚺æNIPTã¯ãåŠåš 10é±0æ¥ããæ€æ»å¯èœã§ãã
ïŒæ€æ»ã®ãäºçŽã¯åŠåš é±æ°ã«é¢ä¿ãªããã€ã§ãå¯èœã§ããïŒ
åœç€Ÿã§ã¯ã15é±ãããŸã§ã®æ€æ»ãæšå¥šããŠãããŸãã
NIPTãšã¯ãè±èªã®Noninvasive prenatal genetic testingã®ç¥ã§ãç¡äŸµè¥²çåºçåéºäŒåŠçæ€æ»ãæå³ããŸãã
ä»ãŸã§ã®åºçå蚺æãšåºå¥ããæ°ååºçå蚺æãšèšãããŠããŸãã
詳ããã¯ãæ°ååºçå蚺æïŒNIPT)ãšã¯ãããåèã«ããŠãã ããã
NIPTæ€æ»ã¯åŠåš 10é±ä»¥éããæ€æ»ãè¡ãããšãã§ããŸãããçŸæ°Žæ€æ»ã¯åŠåš 15ïœ16é±ä»¥éã§ãªããšåããããšãã§ããŸããã
NIPTæ€æ»ã¯æ¯äœããæ¡è¡ããè¡æ¶²ã®ã¿ã䜿ãæ€æ»ãªã®ã§ãèå
ã«åœ±é¿ãäžãããããªãªã¹ã¯ã¯ãããŸããããçŸæ°Žæ€æ»ã¯ãæ€æ»åŸã«èå
ãæµç£ããå¯èœæ§ãçŽ0.1ïœ0.3ïŒ
ïŒ1000人äž1ïœ3人ïŒçšåºŠãããšèšãããŠããŸãã
çŸæ°Žæ€æ»ã¯ãçŸæ°Žäžã«å«ãŸããŠããèå
ã®çŽ°èã調ã¹ãèå
ã«æè²äœã®å€åïŒæè²äœç°åžžïŒããããã©ããã調ã¹ãããã®ç¢ºå®èšºææ€æ»ã§ãã
æ¡åããçŸæ°Žäžã«å«ãŸããŠããèå
ã®çŽ°èãå¢ããããã«çŽ2é±éå¹é€ïŒçŽ°èãå¢ããïŒããæ€æ»æ¹æ³ã®éãã«ãããŸãããããå€ãã®ç°åžžãæ€åºããããšãã§ããŸãã
çŸæ°Žæ€æ»ã®æ€æ»æ¹æ³ã¯ã倧ããåããŠ3ã€ãããŸãã
â æè²äœåææ³
æè²äœã®æ°ã®ç°åžžãæ§é ç°åžžïŒéäœã転座ã倧ããæ¬ å€±ãéè€ïŒãªã©ããããæ€æ»æ³ã§ãæ€åºæ床ãé«ããªãã®ã§é¡åŸ®é¡ã§èŠããªãã¬ãã«ã®åŸ®å°æ¬ 倱ãã¢ã¶ã€ã¯ãªã©ã¯ã¿ãããšãã§ããŸããã
â¡FISHæ³ïŒfluorescence in situ hybridization)æ³
FISHæ³ã§ç¢ºå®èšºæãšãªãã®ã¯å€§ããªæ¬ 倱ãéè€ã§ããã®éšäœã®ç°åžžãå€ç°ãéºäŒåã¬ãã«ã®åŸ®å°æ¬ 倱ãªã©ã¯é©ããŠããŸããã
â¢ãã€ã¯ãã¢ã¬ã€æ³
æè²äœã现ãããã©ãã©ã«ããŠãéãè²ã®èå
ã®ç©è³ªã§æãæ€æ»ããŸããæè²äœåææ³ãããïŒïŒïŒåããã现ããæ€æ»ã§ãã
NIPTæ€æ»ã¯ãéœæ§çäžçããã³é°æ§çäžçãä»ã®é確å®èšºææ€æ»ãšæ¯ã¹éåžžã«é«ãããã確å®èšºææ€æ»ãè¡ãåã®ãªã¹ã¯ã®ç¡ãã¹ã¯ãªãŒãã³ã°æ€æ»ã«æé©ãšèšããŸãã
NIPTãçŸæ°Žæ€æ»ãä¿éºé©å¿å€ãšãªããå
šé¡èªå·±è² æ
ã§ãã
å»çæ©é¢ã«ãã£ãŠããŸããæ€æ»å
容ã«ãã£ãŠéãã¯ãããŸãããçŸæ°Žæ€æ»ã®è²»çšã¯ïŒïŒäžåïœïŒïŒäžåã§ãã
ã³ã©ã ãçŸæ°Žæ€æ»ã§åããããšãšã¯ïŒæµç£ãããªã¹ã¯ã¯ã©ããããïŒãããåèã«ããŠãã ããã
å
šæè²äœæ€æ»ã§ã¯ãïŒïœ22çªã®åžžæè²äœã®ããªãœããŒæ€æ»åã³æ§å¥å€å®ãã¢ããœããŒXïŒã¿ãŒããŒçå矀ïŒãªã©æ§æè²äœã®ç°åžžã«ã€ããŠæ€æ»ãå®æœããŸããããã以å€ã®éºäŒåãåå ãšãªãéºäŒåçŸæ£ããã®ä»ããªãœããŒä»¥å€ã®æè²äœç°åžžãªã©ã¯çºèŠããããšãã§ããŸããã
ãã ãã埮å°æ¬ 倱çã®æ€æ»ãåããããšã§ããã«è©³çŽ°ãªæè²äœç°åžžãçºèŠåºæ¥ãŸãããå
šãŠã®ç°åžžãçºèŠããã«ã¯è³ã£ãŠãããŸããã
ïŒçŸåšã®éºäŒåæ€æ»ã®åéã§ãèå
ã®ç°åžžãå
šãŠçºèŠããæè²äœæ€æ»ã¯ãããŸãããïŒ
NIPT Japanã®æ€æ»ã§èª¿ã¹ãããšãåºæ¥ãçŸæ£ã«ã€ããŠã¯ãNIPT Japanã®NIPTæ€æ»æéããã芧ãã ããã
NIPT Japanã®æ€æ»ã¡ãã¥ãŒã¯ãåçš®ã®å€å®ãã§ããŸãã
æ€æ»é ç®
â åºæ¬æ€æ»ïŒæ§å¥å€å®å«ãïŒ
- ããŠã³çå矀ïŒ21ããªãœããŒïŒ
- ãšãã¯ãŒãºçå矀ïŒ18ããªãœããŒïŒ
- ãããŠçå矀ïŒ13ããªãœããŒïŒ
â¡ å šæè²äœæ€æ»ïŒæ§æè²äœç°åžžæ€æ»ã1çªïœ22çªãX, Yæè²äœïŒ
- ã¿ãŒããŒçå矀ïŒTurnerçå矀ïŒ
- ã¯ã©ã€ã³ãã§ã«ã¿ãŒçå矀ïŒKlinefelter Syndromeçå矀ïŒ
- ããªãã«Xçå矀ïŒTripleXçå矀ïŒ
- ãã®ä» æè²äœæ€æ»
⢠埮å°æ¬ 倱ç
- 1p36æ¬ å€±çå矀
- 4pæ¬ å€±çå矀
- 5pæ¬ å€±çå矀
- 15q11.2æ¬ å€±çå矀
- 22q11.2æ¬ å€±çå矀
æ€æ»çµæã«ã¯ãäžèšã®æ€æ»é ç®ã«ã€ããŠé«ãªã¹ã¯ïŒéœæ§åå¿ïŒãäœãªã¹ã¯ïŒé°æ§åå¿ïŒããæ€æ»çµæãšããŠéç¥ããŸãã
æ€æ»æéã«ã€ããŠã¯ããNIPT Japanã®NIPTæ€æ»æéããã芧ãã ããã
cf.
NIPTã³ã³ãœãŒã·ã¢ã èªå®ã®å»çæ©é¢ã§ã®NIPTæ€æ»
ããŠã³çå矀ïŒ21ããªãœããŒïŒããšãã¯ãŒãºçå矀ïŒ18ããªãœããŒïŒããããŠçå矀ïŒ13ããªãœããŒïŒã®ïŒçš®é¡ã®å€å®ã®ã¿ã
NIPT Japanã§ã¯ãVerinata Health瀟ã«ãŠæ€æ»ãè¡ã£ãŠãããŸãã
Verinata Health瀟ãå
¬è¡šããŠããNIPTæ€æ»ç²ŸåºŠã¯æ¬¡ã®ãšããã§ãã
æè²äœ | N | æ床 | 95% CI | ç¹ç°åºŠ | 95% CI |
---|---|---|---|---|---|
21 | 500 | 99.9% (90/90) | 96.0% â 100.0% | 99.8% (409/410) | 98.7% â 100.0% |
18 | 501 | 97.4% (37/38) | 86.2% â 99.9% | 99.6% (461/463) | 98.5% â 100.0% |
13 | 501 | 87.5% (14/16) | 61.7% â 98.5% | 99.9% (485/485) | 99.2% â 100.0% |
å šæè²äœ | 1330 | 98.70% | 96.1% â 99.6% | 99.95% | 99.62% â 99.99% |
æ§æè²äœ | N | æ床 | 95% CI | ç¹ç°åºŠ | 95% CI | 粟床 | 95% CI | |
---|---|---|---|---|---|---|---|---|
ã¢ããœã㌠X ïŒã¿ãŒããŒçåçŸ€ïŒ |
508 | 95.0% (19/20) | 75.1% â 99.9% | 99.0% (483/488) | 97.6% â 99.7% | – | – | |
XX | 508 | 97.6% (243/249) | 94.8% â 99.1% | 99.2% (257/259) | 97.2% â 99.9% | 98.40% | 96.9% – 99.3% | |
XY | 508 | 99.1% (227/229) | 96.9% â 99.9% | 98.9% (276/279) | 96.9% â 99.8% | 99.00% | 97.7% – 99.7% | |
XXX, XXY, XYY | æ€åºãããå Žåãæ§ç°æ°æ§ãå ±åãããŸãã ããŒã¿æ°ãéãããŠãããããè©äŸ¡å¯Ÿè±¡ããé€å€ |
|||||||
埮å°æ¬ 倱ããã³ ãã®ä»ã®åžžæè²äœç°æ°æ§ |
埮å°æ¬ 倱ããã³ä»ã®åžžæè²äœç°æ°æ§ãæ€åºãããå Žåãå ±åãããŸãã ããŒã¿æ°ãéãããŠãããããè©äŸ¡å¯Ÿè±¡ããé€å€ |
NIPT Japanã®ææºã¯ãªããã¯ã§æ€æ»ãåããããšãåºæ¥ãŸãã
ææºã¯ãªããã¯ã¯ãå
šåœïŒïŒå»é¢ä»¥äžãããŸãã®ã§ããè¿ãã®ã¯ãªããã¯ã§æ¡è¡ãè¡ãããšã§æ€æ»ãåããããšãåºæ¥ãŸãã
NIPTæ€æ»ãšããæå³ã§ã¯åãæ€æ»ã«ãªããŸãã
ããããNIPTã³ã³ãœãŒã·ã¢ã ã«å çããŠãã倧åŠç
é¢çã§å®æœãããŠããæ€æ»ãšNIPT JapanãæäŸããŠããæ€æ»ãšã®éããåæããŸããšæ¬¡ã®ãšããã§ãã
- 幎霢å¶éããªã
- ã«ãŠã³ã»ãªã³ã°ãå¿ é ã§ã¯ãªã
- ã«ããã«ã§æ¥é¢ã¯äžèŠã§ããäžäººã§åæ€ã§ãã
- 1åã®æ¡è¡ã®ã¿ã§æ€æ»ã¯çµäº
- æ€æ»çµæã¯éµéãŸãã¯é»åããŒã¿ãããŠã³ããŒãããæ¹æ³ã§åãåãããšãã§ãã
ãšãã£ãç¹ãéããŸãã
æ€æ»å 容ã§ç¹çããçžéç¹ã¯ã
- å šæè²äœæ€æ»
- æ§æè²äœæ€æ»
- 埮å°æ¬ 倱çæ€æ»
- æ§å¥å€å®
ã®ãµãŒãã¹ãããããšã§ãã
æ€æ»ç²ŸåºŠãè¥å¹²éãããããŸãã
NIPT Japanã®NIPT | 倧åŠç é¢çã®NIPT | ||||
æ€æ»ç²ŸåºŠ | 幎霢 | éœæ§çäžç | é°æ§çäžç | éœæ§çäžç | é°æ§çäžç |
21ããªãœã㌠â»1
|
30æ³ | 94.10% | 99.90% | 61.30% | 99.90% |
35æ³ | 97.60% | 99.90% | 79.90% | 99.90% | |
40æ³ | 99.30% | 99.90% | 93.70% | 99.90% | |
18ããªãœã㌠â»2
|
30æ³ | 30.10% | 99.90% | 10.70% | 99.90% |
35æ³ | 51.70% | 99.90% | 22.90% | 99.90% | |
40æ³ | 79.50% | 99.90% | 51.90% | 99.90% | |
13ããªãœã㌠â»3
|
30æ³ | 13.00% | 99.90% | 4.40% | 99.90% |
35æ³ | 27.50% | 99.90% | 10.40% | 99.90% | |
40æ³ | 58.40% | 99.90% | 30.00% | 99.90% |
â»1ã21ããªãœããŒïŒããŠã³çïŒã®çºç確çã¯ãåŠåš 12é±ã®æ¯èŠªã21ããªãœããŒã®èµ€ã¡ãããåŠåš ããŠãã確ç: Snijder(1999)ã®å€ã䜿çš
â»2ã18ããªãœããŒã®çºç確çã¯ãåŠåš 16é±ã®æ¯èŠªã18ããªãœããŒã®èµ€ã¡ãããåŠåš ããŠãã確ç: Snijder(1995)ã®å€ã䜿çš
â»3ã13ããªãœããŒã®çºç確çã¯ãåŠåš 16é±ã®æ¯èŠªã13ããªãœããŒã®èµ€ã¡ãããåŠåš ããŠãã確ç: Snijder(1995)ã®å€ã䜿çš
éœæ§çäžçã®èšç®ãšçºççã®é¢ä¿ã«ã€ããŠ
NIPTã®çäžçã®èšç®ã¯ãæ床ã»ç¹ç°åºŠã«å ããŠã該åœããæè²äœç°åžžã®çºççãå¿
èŠãšãªããŸãã
éœæ§çäžçã¯ãã®çºççã«ã€ããŠã©ã®å€ãçšãããã§æçµçãªéœæ§çäžçã®çµæã倧ããç°ãªã£ãŠããŸããŸãã
ïŒé°æ§çäžçã«ã€ããŠã¯ã粟床ãé«ãããã©ã®ãããªæç®ã®çºççãçšããŠãå€åã¯ãããŸãããïŒ
çºççãé«ãèšå®ããã°çäžçãäžãããéã«äœãèããã°äžãã£ãŠããŸããŸãã
ãã®çºãéœæ§çäžçã®èšç®ã«ã¯ãã®çºççã«ã€ããŠãã©ã®å€ãçšããããéèŠãšãªããŸãã
äžèšã®èšç®ã§ã¯ãå ¬å¹³ãæããããã倧åŠç é¢çã§æäŸãããŠããNIPTã®çäžçèšç®ã«å€ãçšããããŠãããåŠåš 12é±ã®æ¯èŠªã21ããªãœããŒã®èµ€ã¡ãããåŠåš ããŠãã確çSnijder(1999)ãã®å€ã䜿çšãèšç®ããŸããã
äžéšã®å»çæ©é¢ã§ã¯ç°ãªãçºç確çãçšããŠèšç®ããŠããäŸãããããã®å Žåã¯äžèšã®æ°åãšåçŽã«éœæ§çäžçãæ¯èŒããããšã¯ã§ããŸããã®ã§æ¯èŒããéã¯ã泚æãã ããã
æ°ååºçå蚺æ(ãããããã ã£ããããããã ãã»ãããããã ã£ããããŸãããã ã)ãšã¯ããæ¯äœããæ¡è¡ãããã®è¡æ¶²ãæ€æ»ããããšã«ããèå ã®æè²äœç°åžžã調ã¹ãæ€æ»ãã®ããšã§ãã
æ°ååºçå蚺æãšããå称èªäœã¯ãæ¥æ¬ã§ã®é称åã§ãã
æ¯äœè¡æž
ããŒã«âãã¹ããªã©ã®åŸæ¥ã®è¡æ¶²ã«ããåºçå蚺æãšæ¯èŒããŠãæ床ã»ç¹ç°åºŠãšãã£ãæ€æ»èªäœã®ç²ŸåºŠãããããŠé«ãçºãåŸæ¥ã®åºçå蚺æãšåºå¥ããŠæ°ååºçå蚺æïŒNIPTïŒãšåŒã°ããŠããŸãã
詳ããã¯ãæ°ååºçå蚺æïŒNIPT)ãšã¯ããã芧ãã ããã
ãå®å¿ãã ãããéæ³ã§ã¯ãããŸããã
NIPT Japanã®NIPTæ€æ»ã¯ããã¹ãŠã®æ³åŸãé å®ããããã§æ¡è¡ãšæ€æ»çµæã®éç¥ãè¡ã£ãŠãããŸãã
NIPTæ€æ»ã®æŠèŠã«ã€ããŠ
æ€æ»å¯èœãªåŸ®å°æ¬ 倱çã¯æ¬¡ã®ãšããã§ãã
çå矀 | çºçç |
22q11.2æ¬ å€±çå矀ïŒDiGeorgeçå矀ãvelocardiofacialçå矀ïŒ1 | 4000åã®1 |
1 p36æ¬ å€±çå矀 1 | 4000åã®1ãã10,000åã®1 |
ãšã³ãžã§ã«ãã³çå矀ïŒ15q11.2埮å°æ¬ 倱ïŒ1,2â | 12,000åã®1 |
ãã©ããŒã»ãŠã£ãªãŒçå矀ïŒ15q11.2埮å°æ¬ 倱ïŒ1,2â | 10,000åã®1ãã25,000åã®1 |
ã¯ãªãã¥ãã£ããçå矀ïŒ5p-çå矀ïŒ1,2 | 20,000åã®1ãã50,000åã®1 |
ãŠã«ãã»ãã«ã·ã¥ããŒã³çå矀ïŒ4p-çå矀ïŒ1,2 | 50,000åã®1 |
埮å°æ¬ 倱çæ€æ»ã®éœæ§çäžçã§ãããVerifi Plus åºçåæ€æ»ã®åŸ®å°æ¬ 倱çæ€æ»ã¯ãèšåºãµã³ãã«ãšåæãµã³ãã«ã®äž¡æ¹ã§æ€èšŒãããŠããŸãã
115,000ãè¶ ãããµã³ãã«ã®èšåºã³ããŒãã§ã¯ãVerifi Plus åºçåæ€æ»ã®åŸ®å°æ¬ 倱çæ€æ»ã¯ãåªããå šäœçãªããã©ãŒãã³ã¹ã瀺ããŠããŸãã
åœéœæ§çãäœãããã¹ã倱æçãäœãã22q11æ¬ å€±çå矀ã®éœæ§çäžçïŒPPVïŒã90.0ïŒ ãä»ã®åŸ®å°æ¬ 倱çå矀ã®PPVã10.5ïŒ ãã66.7ïŒ ã®ç¯å²ãšãªã£ãŠããŸãã
åèæç®
1. Gardner RJM, Sutherland GR, Schaffer LG. Chromosome Abnormalities and Genetic Counseling. 4th ed. New York, NY: Oxford University Press; 2012.
2. Jones KL. Smith’s Recognizable Patterns of Human Malformation. 5th ed. Philadelphia, PA: Saunders; 1996.
â ã¢ã¡ãªã«ç£ç§å©Šäººç§å»äŒã¯ãè¶
é³æ³¢ã§äž»èŠãªå
倩æ§ç°åžžãèªãããã女æ§ãåºçå蚺æã«ã€ããŠããã«ã«ãŠã³ã»ãªã³ã°ãšè°è«ãåããããšãæšå¥šããŠããŸãã
* ãã¡ã€ã«äžã®ããŒã¿èšç®ã ã€ã«ãã瀟 2017
æ¡è¡æ¥ããèµ·ç®ããŠæç7æ¥ãæŠã10æ¥çšåºŠã§é»åã¡ãŒã«ã§ãéç¥ããŠãããŸããïŒéµéåžæã®å Žåã¯ïŒïŒæ¥çšåºŠïŒ
æ€æ»æ©é¢ã茞éæ©é¢ã®äºæ
çã«ãããæ€æ»çµæã®éç¥ãŸã§ã®æ¥æ°ãã10æ¥ãè¶
ããŠã14æ¥çšåºŠãããå ŽåãããããŸãã
æ€æ»çµæã®éç¥æžã¯è±æãšãªããŸãã
æ¥æ¬èªã§ã®æ€æ»çµæéç¥ã¯ããããŸããã
éšåçãªåèæ¥æ¬èªèš³ãæ·»ä»ãããŠããã ããŸãããè±æçµæã®ã¿ãæ£åŒãªéç¥æžãšãªããŸãã
åèïŒååïŒã®å Žåãçæ¹ãéœæ§ããããã¯äž¡æ¹ãéœæ§ãšããçµæã«ãªããŸãã
ã¯ããã調ã¹ããäºã¯ã§ããŸãããçæ¹ãç·å ããããã¯äž¡æ¹ãšãç·å ãšããçµæã«ãªããŸãã
ãVerifiãïŒããªãã¡ã€ïŒãšã¯ãããªãã¿ã»ãã«ã¹ç€Ÿãè¡ã£ãŠããNIPTæ€æ»ã®ãµãŒãã¹å称ã§ãã
ããªãã¿ã»ãã«ã¹ç€Ÿãè¡ã£ãŠããNIPTæ€æ»ã«ã¯ããVerifiããšãVerifi Plusããšã®2çš®é¡ããããŸãã
ãVerifiãã®æ€æ»ã¡ãã¥ãŒã¯ã21,18,13çªæè²äœç°æ°æ€æ»ïŒæ§æè²äœæ€æ»ã§ãã
ãVerifi Plusãã®æ€æ»ã¡ãã¥ãŒã¯ããVerifiãã®æ€æ»ã¡ãã¥ãŒã«è¿œå ããããšãã§ãããªãã·ã§ã³ãçšæãããŠããŸãã
è¿œå å¯èœãªãªãã·ã§ã³ã¯ãå
šæè²äœæ€æ»ãšåŸ®å°æ¬ 倱æ€æ»ããããŸãã
ãããŸã§è¡æ¶²ã®èŒžéäžã§åé¡ãèµ·ããããšã¯äžåºŠããããŸããã
茞éã«ã€ããŠã¯ãå³å¯ãªæž©åºŠç®¡çãå¿
èŠãªã¯ã¯ãã³ããç 究çšã®çŽ°èãªã©å»çé¢ä¿ã®åœé茞éã«ãããŠãããã¯ã©ã¹ã®å®çžŸãæã€èŒžéäŒæ¥ãæ
åœããŠãããŸãã
ç
é¢ããè¡æ¶²ãéã¶éã«ã¯ãå³éãªæ¢±å
ãè¡ããé©åãªéé¢åŠçãããäžã§ãæµ·å€ãžçºéããããŸãã
ãŸãã茞å
¥åœåŽã§ã¯ãåäŒæ¥ã®çŸå°æ¯ç€Ÿã責任ããã£ãŠçŸå°ã§éé¢ãè¡ããæ€æ»æ©é¢ãŸã§è¡æ¶²ããå±ãããŠãããŸãã®ã§ãå®å¿ãã ããã
å
šåœã®ææºå»é¢ã§ã¯ãåææ¥ã»æ¥ææ¥ã»ç¥ç¥æ¥ã«æ¡è¡ãè¡ã£ãŠããã¯ãªããã¯ãããããŸãã
ãã ããè¡æ¶²èŒžéã®æé
ã®é¢ä¿ã§ãåææ¥ã»æ¥ææ¥ã»ç¥ç¥æ¥ã®æ¡è¡äºçŽã®å Žåã¯ãäºåã«ãçžè«ãã ããã
ãè¿ãã®ã¯ãªããã¯ãæ¢ãã«ã¯ããNIPT Japanææºã®NIPTæ€æ»ãã§ããå»çæ©é¢ãªã¹ããããåèã«ããŠãã ããã
ãå®å¿ãã ããã
æ€æ»çµæã®ééãããè¡æ¶²æ€äœã®åãéããªã©ã®äºäŸã¯1äŸããããŸããã
æ¡è¡ããå»é¢ã§ã¯ãåŠå©Šæ§1åæ§ããšã«æ¡è¡ãè¡ãããã®å Žã§æ°åãšIDãèšå
¥ãã1åæ§ããšã«å°çšã®èŒžéããã¯ã¹ã«å
¥ããæ€æ»æ©é¢ã«éããŸãã
æ€æ»æ©é¢ã«ãããŠããè¡æ¶²æ€äœã®åé åŸãç¹°ãè¿ã確èªäœæ¥ãè¡ããæ€æ»ã®å®æœãè¡ã£ãŠããŸãã
ãŸããæ€æ»çµæã¯ãã³ã³ãã¥ãŒã¿ãŒã«ããèªåã§åºåããããããçµæãééã£ãŠåºåãããããšã¯ãããŸããã
ãã®ãããä»ãŸã§ã«è¡æ¶²æ€äœã®åãéãããããããæ€æ»çµæã«æ¬æ¥ã®çµæãšã¯ç°ãªã誀ã£ãå
容ãåºåããããããããšã¯ãäžåºŠããããŸããã
æ°ååºçå蚺æïŒNIPTïŒã¯ã確å®èšºææ€æ»ã§ã¯ãããŸããã
æçµçãªèšºæçµæãåŸãããã«ã¯ãçŸæ°Žæ€æ»ãªã©ã®ç¢ºå®èšºææ€æ»ãè¡ãå¿
èŠããããŸãã
çŸæ°Žæ€æ»ã¯ãæ€æ»åŸã«èå
ãæµç£ããå¯èœæ§ãçŽ0.1ïœ0.3ïŒ
ïŒ1000人äž1ïœ3人ïŒçšåºŠãããšèšãããŠãããŸãã
NIPTæ€æ»ã¯ããã®ãããªãªã¹ã¯ãå«ã確å®èšºæãåããåã®äºåã¹ã¯ãªãŒãã³ã°æ€æ»ã§ããããšããç解ãã ããã
NIPTæ€æ»ã¯æ¥µããŠé«ãã®ç²ŸåºŠãèªã£ãŠããŸãããéœæ§çäžçã«é¢ããŠã¯ãé°æ§çäžçããã粟床ãå£ããŸãã
NIPTæ€æ»ã®çµæã«ã€ããŠã¯ãé«ãªã¹ã¯ïŒéœæ§ïŒãšããçµæã§ãã£ãŠããå®éã«ã¯èå
ã«æè²äœç°åžžã¯ç¡ãïŒåœéœæ§ïŒå Žåãããããšã«ã泚æãã ããã
ãªããé°æ§çäžçã¯99.98ïŒ
以äžãšéåžžã«é«ãçäžçã§ãããåœé°æ§ãšãªã£ãŠããŸã確çã¯0.01ïŒ
æªæºãšæ¥µããŠäœã確çã§ããã100ïŒ
ã®çäžçã§ã¯ãªãããšã«ãã泚æãã ããã
ã³ã©ã ãNIPTã®æ€æ»çµæã¯ãã€åããïŒçµæã®æå³ãšç¢ºå®çæ€æ»ãåããäžã§ã®æ³šæç¹ãšã¯ãããåèã«ããŠãã ããã
æ§å¥ã®æ€æ»ã¯ãå
šãŠã®æ€æ»ã³ãŒã¹ã«å«ãŸããŠããŸãã
åžæãããªãå Žåã¯ãéç¥ãããªããµãŒãã¹ãããããŸãã
幎霢å¶éã¯ããããŸããã
æ€æ»å¯Ÿè±¡è
- åŠåš 10é±0æ¥ïœ15é±6æ¥ãŸã§ã®æ¹ïŒ16é±ãè¶ ããŠãæ€æ»ãåããããšã¯å¯èœã§ãããåãåãããã ãããïŒ
- åèãŸãã¯åèåŠåš ïŒååã®åŠåš ïŒ
- äœå€å粟ã»åµåæäŸã«ããåŠåš
- åèäžå æ»äº¡çå矀ïŒVanishing twinsïŒã®æ¹ã¯ãçžè«äžããã
æ€æ»ãããããã§ããªãæ¹
- çæ£è ã®æ¹
- ããªãœããŒæ£è ã®æ¹
- éå»12ã¶æéã«èŒžè¡ãããæ¹
- 幹现èæ²»çãŸãã¯å ç«çæ³ãåããããšãããæ¹
- èåšç§»æ€ããããããšãããæ¹
- ç°æ°æ§ïŒãããããïŒã®æ¹
ïŒâ»ïŒåèåŠåš ã®å Žåæ€æ»ã«å¶éãããããŸãã
ã»æ§æè²äœãå
šæè²äœã埮å°æ¬ 倱æ€æ»ããåæ€ããã ããŸããã
ã»åèåŠåš ã®å Žåã¯13,18,21çªæè²äœæ€æ»+æ§å¥ã®éç¥ã®ã¿å¯èœïŒæ§å¥ã¯çæ¹ãç·å
ããããã¯äž¡æ¹ãšãç·å
ãšããçµæã«ãªããŸãïŒ
åé¡ãªã倧äžå€«ã§ãã
çŸè¡ã®æ³åŸäžã§ã¯ãåœç¶ã®ããšãªããéæ³æ§ã¯ãããŸããã
ãŸããNIPT JapanãæäŸããNIPTã®æ€æ»èªäœã倧å€ä¿¡é Œæ§ãé«ãæ€æ»ã§ãã
ãå®å¿ãã ããã
æ¥æ¬ç£ç§å©Šäººç§åŠäŒã®æéã§ã¯ãåºæ¬çã«ã¯35æ³ä»¥äžã®åŠå©ŠãNIPTæ€æ»ãåããããšãã§ãããšãããŠããŸãã
35æ³æªæºã®å ŽåãNIPTæ€æ»ãåããããŠãåããããšãã§ããªããããåŠåš ææã35æ³ã«ãªããŸã§åŸ
ã€ãšãã£ãéžæããããæ¹ãããã£ããããŸããã
ãŸããNIPTæ€æ»ãåããããšãåºæ¥ãªãåŠå©Šã®æ¹ã¯ãæµç£ã®ãªã¹ã¯ãæãçŸæ°Žæ€æ»ãã粟床ã®äœãåºçå蚺æãåããããéžæè¢ããããŸããã§ããã
NIPT Japanã¯ã
ã»ç掻ãçŠç¥ãåäžããããã«æ
å ±ããµãŒãã¹ãéžæãã¢ã¯ã»ã¹ããæš©å©
ã»èªåã®ææãå°éãããèªåã®èº«äœã«é¢ããããšãèªåèªèº«ã§æ±ºããããæš©å©
ãåŠå©Šã®çæ§ã«ã¯æããšèããŠãããŸãã
ãã®æš©å©ã«ã¯ãåŠåš ã»åºç£ã家æèšç»ãäžåŠãçŸç
ã®äºé²ã»èšºæã»æ²»çãªã©ã®å¿
èŠãªãµãŒãã¹ãå¿
èŠãªæã«åããããããšãå«ãŸããŠããŸãã
ã©ãããå®å¿ããŠNIPT Japanã®NIPTæ€æ»ãå蚺ãªãã£ãŠãã ããã
æ¡è¡ããçµæéç¥ãŸã§ã«ã€ããŠ
NIPTã®æ€æ»çµæã®éç¥æžã®ãµã³ãã«ã«ã€ããŸããŠã¯ãåœç€ŸãŠã§ããµã€ããNIPT Japanã®NIPTæ€æ»æéãã®ãNIPT æ€æ»çµæã®ãµã³ãã«ãã®é ç®ããåç §ãã ããã
è±æã®æ€æ»çµæã®éç¥æžãæ£åŒãªéç¥æžãšãªããŸãããNIPTã®æ€æ»çµæã®éç¥ã®éã«ãéšåçãªåèæ¥æ¬èªèš³ã®ãæ€æ»çµæ説æåèè³æïŒPDFïŒããæ·»ä»ããŠãæ¡å ããŠããŸãã
ãæ€æ»çµæ説æåèè³æïŒPDFïŒãïŒ378 KBïŒã®ããŠã³ããŒã
ãã®ãæ€æ»çµæ説æåèè³æïŒPDFïŒãã«ããéãã
- æ€æ»çµæã§éœæ§ïŒãªã¹ã¯ãé«ãïŒãšå€å®ãåºãå Žåã¯ã該åœããéºäŒåçªå·ã®çµæã®èšè¿°ãèµ€åã§ãPOSITIVEããšè¡šç€ºãããŸãã
- é°æ§ã®å Žåã¯ãèšè¿°ããããŸãããïŒ21,18,13çªã®æè²äœãé€ãïŒ
- 埮å°æ¬ 倱ããã³ä»ã®åžžæè²äœç°æ°æ§ãæ€åºãããå Žåãäœçªæè²äœã«ç°åžžãããããŸãã¯ãã©ã®ç®æã®åŸ®å°æ¬ 倱ãããããšãã£ãå 容ãéç¥ãããŸãã
åœç€Ÿã®å¶æ¥æéå ã§æ€æ»çµæã®éç¥ãåæ€è æ§ã«è¡ã£ãŠãããŸãã
NIPTã®æ€æ»çµæã®ã¡ãŒã«ã§ã®ãæ¡å
ã¯ã
â éç¥çµæã«ã¢ã¯ã»ã¹ã§ãããŠã§ããµã€ãã®ã¢ãã¬ã¹
â¡ã¢ã¯ã»ã¹ã«å¿
èŠãªãã¹ã¯ãŒã
ãšãå¥ã
ã®ã¡ãŒã«ã§ãæ¡å
ããŠãããŸãã
ãããã®ãæ¡å
ã®ã¡ãŒã«ã¯ã次ã®ã¡ãŒã«ã¢ãã¬ã¹ããéä¿¡ãããŸãã
noreply@nipt.online
nipt@niptjapan.com
äºåã«ã¡ãŒã«ã®åä¿¡èšå®ãããŠã確å®ã«ã¡ãŒã«ãåãåãããšãã§ããããã«ãé¡ãããããŸãã
倧å€ãŸãã§ãããæ¡è¡ããè¡æ¶²äžã®èå
DNAéã足ããªãå Žåããäœããã®åå ã«ããæ€æ»çµæãåºãªãã£ãå Žåãªã©ã«ã¯ãååæãšãªãéåžžãããæéãèŠããŸãã
ååæã®çµæãä¿çå€å®ã®å Žåã¯ãåæ¡è¡ãšãªããŸãã
ãªããè¿œå æ€æ»è²»çšã¯ããããŸããã
ã³ã©ã ãNIPTã®æ€æ»çµæã¯ãã€åããïŒçµæã®æå³ãšç¢ºå®çæ€æ»ãåããäžã§ã®æ³šæç¹ãšã¯ïŒãããåèã«ããŠãã ããã
å¿
ãçŸæ°Žæ€æ»ãåããªããã°ãªããªããšããããšã¯æããŸããã
æçµçã«ã¯ãèªèº«ã®å€æãå°éãããŸãã
ãªããNIPTã§æ€æ»çµæãé«ãªã¹ã¯ïŒéœæ§ïŒãšå€å®ãããå Žåã¯ã確å®èšºæïŒçŸæ°Žæ€æ»ã絚æ¯æ€æ»ïŒã«ãã£ãŠç¢ºèªããäºãã§ããŸãã
çŸæ°Žæ€æ»ã¯ãæµç£ãæ»ç£ãšãã£ããªã¹ã¯ã300åã®1çšåºŠãããšèšãããŠãããŸãã®ã§ããããã€ãå»ãšãçžè«ãã ããã
ãªãããããã€ãå»ã§ç¢ºå®èšºææ€æ»ããåæ€ãããå Žåãåœç€Ÿã«ãæ¯æãããNIPTæ€æ»è²»çšãäžéãšããŠãçŸæ°Žæ€æ»ïŒç¢ºå®ç蚺ææ€æ»ïŒã®æ€æ»è²»çšã®å®è²»ãè² æ
ããŸãã®ã§ãå®å¿ãã ããã
ïŒå
¥é¢è²»ã蚺å¯æã亀éè²»çã®è² æ
ã¯è¡ã£ãŠãããŸãããïŒ
çŸæ°Žæ€æ»ã«ã€ããŠã¯ã³ã©ã ãçŸæ°Žæ€æ»ã§åããããšãšã¯ïŒæµç£ãããªã¹ã¯ã¯ã©ããããïŒãããåèã«ããŠãã ããã
ãŸãã絚æ¯æ€æ»ã«ã€ããŠã¯ã³ã©ã ã絚æ¯æ€æ»ãšã¯ïŒçŸæ°Žæ€æ»ãšæ¯èŒããã¡ãªããã»ãã¡ãªãããã玹ä»ãããåèã«ããŠãã ããã
ããªãã¿ã»ãã«ã¹ç€Ÿããæ€æ»çµæã®éç¥ã¯ãæ¡è¡æ¥ãã5æ¥ïœ10æ¥åŸã«åœç€Ÿã«å±ããŠãããå±ã次第åœç€Ÿã®å¶æ¥æéå
ã«é»åã¡ãŒã«ãŸãã¯å°æžã§ãé£çµ¡ãããããŸãã
éç¥æ¥ã¯æ€æ»äŒç€Ÿã®æ··éç¶æ³ã«ãã£ãŠãååŸããŠããŸãã
è²»çšããã£ã³ã»ã«ã«ã€ããŠ
NIPTæ€æ»æéã¯å»çè²»æ§é€ã®å¯Ÿè±¡ã«ã¯ãªããŸããã
ãã®ä»ã®åŠåš ã»åºç£ã«æããè²»çšã®ãã¡1幎éã®å®¶æå šå¡ã®å»çè²»ã10äžåãè¶ ããå Žåã¯ã確å®ç³åããããšæãéããçšéãæ»ããããããŸããã
åŠåš ããåºç£ãŸã§ã«ãããè²»çšã«ã€ããŠã¯ãã¡ãã®ã³ã©ã ããåèã«ããŠãã ããã
æ€æ»ïŒæ¡è¡æ¥ïŒåœæ¥äžãŸã§ã«ãæ¯æããã ããã
ãç³èŸŒã¿æã«ãæ¯æãããã ãå¿
èŠã¯ãããŸããã
ãæ¯æãã¯ã¯ã¬ãžããã«ãŒãïŒããããã«ãŒãïŒæ±ºæžãéè¡æ¯èŸŒããéžã³ããã ããŸãã
ïŒïŒïŒã¯ã¬ãžããã«ãŒãïŒããããã«ãŒãïŒæ±ºæž
SquareïŒã¹ã¯ãšã¢ïŒãå©çšããŸãã®ã§ãã«ãŒãæ
å ±ãå®ãããŠå®å¿ã§ãã
ïŒïŒïŒéè¡æ¯èŸŒ
ãäºçŽç¢ºå®åŸãã¡ãŒã«ã«ãŠåŒç€Ÿéè¡å£åº§æ
å ±ããé£çµ¡ããããŸãã®ã§ã
éèæ©é¢ã®çªå£ãããã¯ATMãããããã³ãã³ã°ãããæ¯èŸŒãã ããã
æ¯èŸŒææ°æã¯ã客æ§ãè² æ
ãšãªããŸãã
ãªãã
ã¯ã¬ãžãã決æžããéè¡æ¯èŸŒãžã®æ¯ææ¹æ³ã®å€æŽã
éè¡æ¯èŸŒããã¯ã¬ãžãã決æžãžã®æ¯ææ¹æ³ã®å€æŽã
ã©ã¡ããã§ããŸãã®ã§ãå®å¿ãã ããã
ãããã€ãå»ããã®ä»ã®å»çæ©é¢ã§ç¢ºå®èšºææ€æ»ããåæ€ãããå Žåãåœç€Ÿã«ãæ¯æãããNIPTæ€æ»è²»çšãäžéãšããŠãçŸæ°Žæ€æ»ã»çµšæ¯æ€æ»ïŒç¢ºå®ç蚺ææ€æ»ïŒã®æ€æ»è²»çšã®å®è²»ãè² æ
ããŸãã®ã§ãå®å¿ãã ããã
ïŒå
¥é¢è²»ã蚺å¯æã亀éè²»çã®è² æ
ã¯è¡ã£ãŠãããŸããããŸããSNPãã€ã¯ãã¢ã¬ã€è§£æã¯å¯Ÿè±¡å€ãšãªããŸãã®ã§ãäºæ¿äžãããïŒ
ããã£ã³ã»ã«ã«ã€ããŠã
æ¡è¡ãå®æœãããŸã§ã§ããã°ãã£ã³ã»ã«å¯èœã§ãã®ã§ãé£çµ¡ãã ããã
ãã®éã®ãã£ã³ã»ã«è²»çšã¯ããããŸããã
æ¡è¡åŸã®ãã£ã³ã»ã«ã¯ã§ããŸããã®ã§ãäºæ¿ãã ããã
ïŒæ¡è¡åŸã«éç¥çµæãç¥ããããªããšããå Žåã¯ãåœç€Ÿããæ€æ»çµæã®éç¥ã¯è¡ããŸãããããããæ¡è¡åŸã®ãã£ã³ã»ã«ã¯ã§ããŸããã®ã§ãäºæ¿ãã ãããïŒ
ããè¿éã«ã€ããŠã
茞éäžã®åé¡ãæ€æ»æ©é¢ã®åé¡ããŸãã¯ãåœç€Ÿã®äºæ
ã«ãããŠæ€æ»ãå®æœã§ããªãã£ãå Žåã«ã¯ãå
šé¡è¿éãšãããŠããã ããŸãã
ãå®å¿ãã ããã
â»ã泚æäžãã
æ¡è¡åŸã®ä»£éæ¯æããå¯èœã§ãã
ãã®ãããã客æ§éœåã«ããè¿éããå Žåã«ã¯ãè¿éäºåææ°æãšããããŸããŠ8,000åãè«æ±ãããŠããã ããŸãã
åœå
ã®NIPTæ€æ»è²»çšãšæ¯ã¹ããšå®ãäŸ¡æ Œãšãªã£ãŠããŸãã
ããããäžçãèŠæž¡ããšåœå®¶ã®ä¿éºå¶åºŠã§NIPTæ€æ»ãå®æœããŠããåœãããã®ã§ãä¿éºé©çšå€ã®æ¥æ¬ã§ã®NIPTæ€æ»ã¯å®ãäŸ¡æ Œãšã¯èšããŸããã
ãŸããNIPT Japanã¯ãNIPTæ€æ»ãåããããã®äºåæ
å ±ã¯ã§ããã ãããããããåŠå©Šã®æ¹ã
ã«æäŸããããšèããŠãããã«ãŠã³ã»ãªã³ã°ãå¿
èŠãªæ¹ã«ã¯å°é家ãå¥éææã§ã玹ä»ããŠãããŸãã
å»çè¡çºã§ããéºäŒã«ãŠã³ã»ãªã³ã°ãšNIPTæ€æ»ãµãŒãã¹ãšãå®å
šã«åºåãããåœç€Ÿã¯NIPTæ€æ»ã®ã¿ãæäŸããŠããã®ã§ãå®ããæäŸã§ããŠããã®ã ãšæããŸãã
äŸ¡æ Œãå®ãã®ã§æ€æ»ã®è³ªãäœããšããããšã¯ããããŸããã
ãå®å¿ãã ããã
æ€æ»æéã«ã€ããŸããŠã¯ãNIPT Japanã®NIPTæ€æ»æéããã芧ãã ããã
ïŒïŒ¡ïŒæ€æ»ïŒ21,18,13æè²äœæ€æ»ïŒæ§æè²äœæ€æ»ã¯ç·é¡165,000åïŒçšèŸŒïŒ
ïŒïŒ¢ïŒæ€æ»ïŒå
šæè²äœæ€æ»ã¯ç·é¡176,000å(çšèŸŒ)
ïŒïŒ£ïŒæ€æ»ïŒå
šæè²äœïŒåŸ®å°æ¬ 倱æ€æ»ã¯ãç·é¡198,000åïŒçšèŸŒïŒ
ãšãªããŸãã
åœç€Ÿã§ã®äžçªäººæ°ã®æ€æ»ã¯ãïŒCïŒæ€æ»ã§ãã
ãã®è²»çšã¯ãæ¡è¡è²»ãæ€äœèŒžéè²»ãæ€æ»èª¬æè²»çšçå«ãã äŸ¡æ Œã§ãã
ãŸããäžãäžéœæ§ã®çµæãåºãå Žåã«ã¯ã確å®èšºææ€æ»ãåéšãããå ŽåãNIPT Japanã«ãæ¯æãããNIPTæ€æ»è²»çšãäžéãšããŠãçŸæ°Žæ€æ»ã»çµšæ¯æ€æ»ïŒç¢ºå®ç蚺ææ€æ»ïŒã®æ€æ»è²»çšã®å®è²»ãè² æ
ããŸãã®ã§ããå®å¿ãã ããã
ïŒå
¥é¢è²»ã蚺å¯æã亀éè²»çã®è² æ
ã¯è¡ã£ãŠãããŸããã®ã§ãäºæ¿ãã ããããŸããSNPãã€ã¯ãã¢ã¬ã€è§£æã¯å¯Ÿè±¡å€ãšãªããŸãã®ã§ãäºæ¿äžãããïŒ
æ€æ»å 容ã«ã€ããŸããŠã¯ãæ€æ»ã¡ãã¥ãŒãšæéããã芧ãã ããã
éºäŒåçŸæ£ã«ã€ããŠ
ã¢ã³ãžã§ã«ãã³çå矀ãšã¯ãå€ãã®éºäŒæ
å ±ãè©°ãŸã£ãæè²äœã®ç°åžžã«ãã£ãŠèµ·ããå
倩æ§ã®çŸæ£ã§ãã
ã¢ã³ãžã§ã«ãã³çå矀ã¯ã15çªæè²äœã«ååšããããUBE3AããšããéºäŒåã®åãã倱ãããããšã§çºçããŸãã
é床ã®ç²Ÿç¥é æ»ãäžå¿ãšããäžæ¢ç¥çµæ©èœé害ãäž»ãªçç¶ã§ãã
詳ããã¯ãåœç€Ÿã®ã³ã©ã
ãã¢ã³ãžã§ã«ãã³çå矀ãšã¯ïŒç¹åŸŽãåå ãæ²»çæ³ã«ã€ããŠè§£èª¬ã
ããåç
§ãã ããã
4pæ¬ å€±çå矀ã¯ã4çªæè²äœãæ¬ ããããšã§èµ·ããæè²äœç°åžžã§ãã
4pæ¬ å€±çå矀ã®ã»ãšãã©ã®å人ã¯ãããçšåºŠã®çºéãšç¥çé 延ãæããŠããã軜床ããé床ã®åœ±é¿ãåããŠããŸãã
ãã®ä»ã®èããããå¥åº·äžã®æžå¿µã«ã¯ãé£èŽãå¿èãç®ãè³ãéªšæ Œã尿路系ã®ç°åžžãããã³çºäœïŒäžè¬çã«ã¯å¹Žéœ¢ãšãšãã«æ¶ããŸãïŒãå«ãŸããŸãã
ã³ã©ã ã4pãã€ãã¹çå矀ã®ç¹åŸŽãšåå ãæè²äœç°åžžããããåèã«ããŠãã ããã
ã¯ãªã»ãã¥ã»ãã£ããçå矀ã¯ã5çªæè²äœãæ¬ ããããšã§èµ·ããæè²äœç°åžžã§ããç²é«ãåç«ã®ãããªæ³£ã声ãããããšãããç«é³Žãçå矀ãšååãã€ããããŸããã
ã¯ãªã»ãã¥ã»ãã£ããçå矀ã®ã»ãšãã©ã®æ£è ã¯ãããçšåºŠã®çºéé 延ãšç¥çé 延ã䌎ããéåžžã¯äžåºŠããé床ã®åœ±é¿ãåããŸãããã®ä»ã®èããããå¥åº·äžã®æžå¿µã«ã¯ãå 倩æ§ã®å¿èæ¬ é¥ãçºäœãèæ±åŽåŒ¯çãããã³äžè ¹éšã®ãã«ãã¢ã®çºçïŒéŒ åŸãã«ãã¢ïŒãå«ãŸããŸãã
ã³ã©ã ã5pæ¬ å€±çå矀ãšã¯ïŒç¹åŸŽãšåå ã«ã€ããŠãããåèã«ããŠãã ããã
ãã©ããŒã»ãŠã£ãªãŒçå矀ã¯ã15q11-q13ã®ç¶æ§æè²äœåŸ®çŽ°æ¬ 倱ãããã¯ã15çªæè²äœæ¯æ§ç芪æ§ãã€ãœããŒã«ãã£ãŠèµ·ããæè²äœç°åžžã§ãã
é£æ¬²äžæ¢ã®ç°åžžã«ããé£æ¬²ãæå¶ããããé£ã¹ç¶ããŠããŸããšããçç¶ãèŠãããŸãã
ãã©ããŒã»ãŠã£ãªãŒçå矀ã¯ãé床ã®éåçºéé
æ» ã粟ç¥é
æ» ãé床ã®èšèª é害ãªã©ãç¹åŸŽãšããŸããå°é çãçæ£çºäœãå€ãã
çåŸ6ãæé ã«çºè²é
æ»ãåããŠèªãããããã©ããŒã»ãŠã£ãªãŒçå矀ã«ç¹æã®èšåºç城åã¯1æ³ããããŸã§é¡åšåãããæ£ç¢ºãªèšåºèšºæã«è³ããŸã§ã«æ°å¹ŽãèŠããããšããããŸãã
ã³ã©ã ããã©ããŒãŠã£ãªãŒçå矀ãšã¯ïŒç¹åŸŽãšæ²»çæ³ã«ã€ããŠãããåèã«ããŠãã ããã
1çªæè²äœãæ¬ ããããšã§èµ·ããæè²äœç°åžžã§ããæé·é害ãé£æ²»æ§ãŠããããé床粟ç¥çºéé æ»ãªã©ã®çç¶ãèŠãããŸãã
æé·é害ãé床粟ç¥çºéé æ»ãé£æ²»æ§ãŠããããªã©ã®çç¶ãèŠãããŸãã
èœã¡ããŒãã çŒãå°ã£ãé¡ãªã©ã®ç¹åŸŽçãªé¡ãã»ãŒå
šäŸã«èªããããŸãã
ä¹³å
æã«ã¯çç·åŒµäœäžãåºä¹³äžè¯ãèªããããããšããããŸãã
å 倩æ§å¿çŸæ£ãé£èŽãæèŠãçœå éãè¥æºãçšã«ç¥çµèœçŽ°èè «ã®å䜵çãçããããšããããŸãã
ãã£ãžã§ãŒãžçå矀ïŒDiGeorgeçå矀ïŒã¯22q11.2æ¬ å€±çå矀ãšãåŒã°ããå°å æ ¢æ§ç¹å®çŸç ã«æå®ãããŠããé£ç ã§ãã
å 倩æ§å¿çŸæ£ãå ç«äžå šãçºéé 延ãå£èè£ãäœã«ã«ã·ãŠã è¡çãªã©ãå šèº«ã®å€éšäœã«çç¶ããããããè€åçŸæ£ã§ãã
ãã£ãžã§ãŒãžçå矀ã®æ»å ã®9å²ã¯å¿çŸæ£ã«ãããã®ã§ãã
ã³ã©ã ããã£ãžã§ãŒãžçå矀ã®ç¹åŸŽãšåå ãæè²äœç°åžžããããåèã«ããŠãã ããã
ã€ã³ãçå矀ïŒXYYçå矀ïŒã®äººã¯ããããåæ§çã§ãã
ã€ã³ãçå矀ã®äžéšã®äººã¯å¹³å身é·ãè¶
ããŠããå ŽåããããŸãããä»ã®èº«äœçç¹åŸŽã«ã¯åœ±é¿ããŸãããæ§ççºéãæ£åžžã§ãã
ã€ã³ãçå矀ã®äººã¯ãåŠç¿é害ãçºè©±ã®é
延ãè¡åé害ã®ãªã¹ã¯ãé«ããªããŸãã
ãŸããã€ã³ãçå矀ã®æ£è
ã®äžéšã¯ãèªéçã¹ãã¯ãã©ã é害ãšèšºæãããŠããŸãã
ã€ã³ãçå矀ã®çç¶ã¯äººã«ãã£ãŠå€§ããç°ãªããŸãããäžè¬çã«è»œåºŠã§ãããã€ã³ãçå矀ã®äžéšã®äººã¯èšºæãããªããŸãŸã«ãªãããšããããŸãã
ã³ã©ã ãXYYçå矀ïŒã€ã³ãçå矀ïŒãšã¯ïŒçç¶ãç¹åŸŽã«ã€ããŠè§£èª¬ãããåèã«ããŠãã ããã
ã¯ã©ã€ã³ãã§ã«ã¿ãŒçå矀ã¯ãç·ã®åãèªåã®çŽ°èã®äžéšãŸãã¯ãã¹ãŠã«Xæè²äœã®äœåãªã³ããŒãæã£ãŠãããšãã«çºçããŸããããã¯éåžžãå€èŠã«å€§ããªéãã¯çŸããŸãããã以äžãå«ãæ§ã ãªåŸ®åŠãªç©ççãªéããåŒãèµ·ãããŸãïŒ
- å¹³å身é·ãããèãé«ã
- çèã®ç·åŒµã匱ã
- çæ®èœåã®äœäž
ä»ã®ç¹åŸŽãšããŠã¯ãæ²ãã£ãå°æãèãå®å šã«ãŸã£ããã«ããã®ãé£ãããèžã«å°ããªããŒã¿ãããããšãªã©ããããŸãã
ã¯ã©ã€ã³ãã§ã«ã¿ãŒçå矀ã®äººã¯ãéåžžã®ç¯å²ã®ç¥èœãæã£ãŠããŸãããäžéšã®åŠç¿é害ãé³å£°/è¡šçŸèšèªã®é 延ãããèŠãããŸããã¯ã©ã€ã³ãã§ã«ã¿ãŒçå矀ã®äººã®äžã«ã¯ãå¥åº·ãšçºéã«é倧ãªæžå¿µãæ±ã人ãããã°ã泚ç®ãã¹ãç¹åŸŽããã£ããšããŠãå°æ°ã§ãçç¶ãããããšããç¥ããªã人ãããŸãã
ã³ã©ã ãã¯ã©ã€ã³ãã§ã«ã¿ãŒçå矀ã®ç¹åŸŽãšå䜵çãããåèã«ããŠãã ããã
ããªãã«Xçå矀ïŒ47,XXXãŸãã¯ããªãœããŒXïŒã¯å¥³æ§ç¹æã®çŸæ£ã§ãé垞女æ§ã¯ãXXãã®æè²äœãæã£ãŠããŸãããããã«1æ¬å€ããXXXããšãªã£ãå Žåã«çºçããŸãã
èŠãç®ãä»ã®å¥³æ§ãšå€§ããç°ãªãããšã¯ãããŸããããå¹³åãããèãé«ãããšãæ²ãã£ãå°æãç®ã®å
åŽã®è¿ãã«ããç®èã®ã²ã ãå¹³ããªè¶³ãªã©ã埮åŠãªèº«äœçãªéããçããããšããããŸãã
çºäœãè
èãå°¿çæ®åšãå¿èã®ç°åžžãäžåŠçãã¿ãããããšããããŸãã
ããªãã«Xçå矀ã®äººã¯ãç¥çéããã¯ãããŸããããåŠç¿é害ãšé³å£°ã»è¡šçŸèšèªã®é
延ã¯ããèŠãããŸãã
ããªãã«Xçå矀ã®äººã®äžã«ã¯ãå¥åº·ãšçºéã«é倧ãªæžå¿µãæ±ã人ãããã°ã泚ç®ãã¹ãç¹åŸŽãã»ãšãã©ãªããããªãã«Xçå矀ã§ããããšãç¥ããªã人ãããŸãã
ã³ã©ã ãããªãã«Xçå矀ïŒããªãœããŒXïŒãšã¯ïŒç¹åŸŽãçç¶ã«ã€ããŠã解説ïŒãããåèã«ããŠãã ããã
ã¿ãŒããŒçå矀ïŒ45,XãŸãã¯ã¢ããœããŒXãšåŒã°ããããšããããŸãïŒã¯å¥³æ§ç¹æã®çŸæ£ã§ãé垞女æ§ã¯ãXXãã®æè²äœãæã£ãŠããŸããããã®ãã¡1æ¬ã®æè²äœã®å
šäœãŸãã¯äžéšãæ¬ å€±ããå Žåã«çºçããŸãã
身é·ãäœãããšãæ§çºéã®é
ããç¹åŸŽã§ãã
ãã®ä»ã«ããå¿èãè
èã®åé¡ãèªå·±å
ç«é害ãèŽåãšèŠåã®åªå€±ããã®ä»ã®å¥åº·åé¡ãªã©ãä»ã®å¥åº·åé¡ãæ±ããŠããå¯èœæ§ãé«ããªããŸãã
ã¿ãŒããŒçå矀ã®äººã¯éåžžãç¥çé害ã¯ãããŸããããç¹å®ã®åŠç¿é害ãçºè©±ãŸãã¯è¡šçŸåã®èšèªé
延ãããå ŽåããããŸãã
çç¶ã®çšåºŠã¯å人差ã倧ãããå¥åº·ãšçºéã®åé¡ãæ·±å»ãªäººãããã°ãå°ãªã人ãããŸãã
ã³ã©ã ã女æ§ã«ãããã¿ãŒããŒçå矀ãšã¯ïŒãããåèã«ããŠãã ããã
13ããªãœããŒïŒãããŠçå矀ïŒãšã¯ã46æ¬ããæè²äœã®ãã¡ãéåžžã¯2æ¬ã§ãã13çªæè²äœã1æ¬å¢ããèš3æ¬ã«ãªãããšã§èµ·ããå
倩ç°åžžçå矀ã§ãã
åºçå
ã®5,000ïœ12,000人ã«1人ãšãããé«éœ¢åºç£ã«ãªãã»ã©ãªã¹ã¯ãé«ãŸãããšãªã©ãç¹åŸŽãšãããŠããŸãã
åå®®å ã§ã¯æ£åžžã«è²ã€ãã®ã®ãè¶ é³æ³¢æ€æ»ãã¹ã¯ãªãŒãã³ã°æ€æ»ã§ãå€å¥ãå¯èœã§ãã
æ€æ»çµæã§ãã¡ããéœæ§ã§ããã°ãå»ççã»ç€ŸäŒçãªãµããŒãã®æºåãèããå¿ èŠãããã§ãããã
13ããªãœããŒã®åã©ãèµ€ã¡ããã®çŽ80ïŒ
ã¯ç
ç¶ãéãããã«çåŸ1ãæãåã«æ»äº¡ããããšãããã£ãŠããŸãã
ãŸãã1幎以äžçåã§ããå²åã¯10ïŒ
æªæºã§ãã
1幎以äžçåããåèµ€ã¡ããã®çºéãçºè²ã¯ãã£ããã§ãããåšå²ã®èšèãç解ããŠç¬é¡ã声ã§åå¿ããããšãã§ããæå¬ã®ããåã©ããå€ãããŸãã
ã³ã©ã ãæè²äœç°åžžã«ãã£ãŠèµ·ãã13ããªãœããŒã®ç¹åŸŽãããåèã«ããŠãã ããã
18ããªãœããŒïŒãšãã¯ãŒãºçå矀ïŒã¯ã46æ¬ããæè²äœã®ãã¡ãéåžžã¯2æ¬ã§ãã18çªæè²äœã1æ¬å¢ããèš3æ¬ã«ãªãããšã§èµ·ããå
倩ç°åžžçå矀ã§ãã
18ããªãœããŒïŒãšãã¯ãŒãºçå矀ïŒã¯ã女å
ã«å€ãçç¶ã§ãç·å
ã§ã¯ç£ãŸããŠããããšãªãæµç£ããããšãã»ãšãã©ãšãªã£ãŠããŸãã
å²åã§ã¯3,000人ãã8,000人ã«1人ãšèšãããŠãããé床ã®ç¥çé害ãå¥åœ¢ãªã©ãããã«ã¯å
倩æ§ã®å¿çŸæ£ãšãã£ãçç¶ãç¹åŸŽã§ãã
18ããªãœããŒïŒãšãã¯ãŒãºçå矀ïŒã§çãŸããåã©ãã®çåŸ1幎ã§ã®çåçã¯ã10%æªæºã§ãã
ä»®ã«çåããŠãå
倩æ§ã®å¿çŸæ£ãå¿
ãããããšãããéåžžã®ç€ŸäŒç掻ãéããå¯èœæ§ã¯ã»ãšãã©ãããŸããã
詳ããã¯åœç€Ÿã®ã³ã©ã ããåç
§ãã ããã
æè²äœç°åžžã«ãã£ãŠèµ·ãã18ããªãœããŒã®ç¹åŸŽ
ãã£ãšãããç¥ãããçŸæ£ã§ãããå€ãã®æ¹ãå±æ§ããŠããã®ãããŠã³çã§ãã
21çªæè²äœã¯éåžž2æ¬ã§ãããããŠã³çå矀ã®å Žå3æ¬ãããŸãã
é«éœ¢åºç£ã§çãŸããŠããããšãå€ããå²åã¯500人ã«1人ã§ãã
ããŠã³çã¯ç¬ç¹ã®é¡ã€ãããã£ãšãç¹åŸŽçãªçç¶ã§ãããã
ãŸãå°æã®é¢ç¯ãïŒã€è¶³ããªããçèã®ç·åŒµåã®äžè¶³ãç¥èœçºéã®é害ãªã©ã®çç¶ããããŸãã
çç¶ã«ã¯å人差ãåºãããç¹ãç¹åŸŽã§ãã
ããã«å¿èç
ãçœè¡ç
ããŠããããèºèç³»ã®å¥åœ¢ãèŠèŠã»èŽèŠé害ãæµæåã®äœããªã©ãå䜵çãšããŠçãããããªã£ãŠããŸãã
å»ççã瀟äŒçãªãµããŒãã®æºåãå¿
èŠã§ãã
åœç€Ÿã®ã³ã©ã èšäºãããŠã³çã¯ãã€ãããïŒããŠã³çã®èµ€ã¡ãããçãŸãã確çããåç §ãã ããã
æ€æ»ã®äºçŽã«ã€ããŠ
ãäžäŸ¿ããããããŠããç³ãèš³ããããŸããã
äºçŽãã©ãŒã ãäœããã®äžå ·åã§å©çšã§ããªãå Žåã¯ãäžèšã®Emailã¢ãã¬ã¹ã«ç©ºã¡ãŒã«ããéããã ããã
äºçŽã«å¿ èŠãªç³è«æ å ±ãèªåEmailã§ãé£çµ¡ããããŸãã
空ã¡ãŒã«éä¿¡ã¢ãã¬ã¹ïŒ
åœç€Ÿã§ã¯ããäºçŽå
容ã®èãééãçãç¡ãããã«ããªã³ã©ã€ã³ããã®ãäºçŽããé¡ãããŠãããŸãã
ãç解ãååã®ã»ã©ããããããé¡ãããããŸãã
ãªããNIPTã®ãäºçŽã¯åŠåš é±æ°ã«é¢ä¿ãªãããã€ã§ãè¡ãããšãã§ããŸãã
æ¡è¡åœæ¥ãŸã§ã¯ãã£ã³ã»ã«æãããããŸããã®ã§ãå®å¿ãã ããã
ãããã質åã®ããã£ã³ã»ã«ãè¿éã¯å¯èœã§ããïŒãããåç §äžããã
ã«ãŠã³ã»ãªã³ã°ã«ã€ããŠ
åœç€Ÿã§ã¯ãèšåºéºäŒå°éå»ã«ãããªã¢ãŒãã§ã®éºäŒã«ãŠã³ã»ãªã³ã°ãåžæè
ã«å®æœããŠãããŸãã
äžå®ãªããšãæ©ãã§ããããšããã²ãçžè«ãã ããã
å®å šäºçŽå¶ã§30å10,000åã§ããïŒãåžæäºå®æ¥ã®1é±éåãŸã§ã«ãç³èŸŒã¿äžãããïŒ
詳现ã¯ãåºçå蚺æãšéºäŒã«ãŠã³ã»ãªã³ã°ããã芧ãã ããã
ãªããNIPT Japanã§ã¯ãååãªãµããŒããåããŠé ãããã®æ
å ±åéããµããŒãæ¥åãªã©ãäž»ã«è¡ã£ãŠãããŸãã
ãæ°è»œã«ãçžè«ãã ããã